Current location:Home > Pharmaceutical
Product
Factory Sells Best Quality Rimonabant 168273-06-1 with USP We supply high quality Rimonabant (CAS 168273-06-1), in stock, factory directly supply to clients, lower prices, more competitiveness.
What is the Rimonabant ?
Rimonabant is White or almost white crystalline powder, while it's Molecular Formula is C22H21Cl3N4O. Rimonabant is a selective antagonist of CB1 with IC50 of 13.6 nM and EC50 of 17.3 nM in hCB1 transfected HEK 293 membrane
What is the CAS number for Rimonabant ?
The CAS number of Rimonabant is 168273-06-1.
More information of Rimonabant 168273-06-1 are:
|
Synonyms |
1-(2,4-Dichlorophenyl)-5-(4-chlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide;5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxylicacid N-(piperidin-1-yl)amide;A 281;Acomplia;N-Piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide;SR 141716; |
|
CAS?Number |
168273-06-1 |
|
Molecular Formula |
C22H21Cl3N4O |
|
Molecular Weight |
463.794 |
|
Density |
1.41 g/cm3 |
|
Melting Point |
230-240oC |
|
Boiling Point |
627.6oC at 760 mmHg |
|
Flash Point |
333.3oC |
|
HS CODE |
2942000000 |
|
PSA |
50.16000 |
|
LogP |
6.26740 |
|
Pka |
11.31±0.20(Predicted) |
What is Rimonabant (168273-06-1) used for?
Rimonabant is a first-in-class drug launched as an oral treatment for obesity, and its mechanism of action involves the selective antagonism of cannabinoid type 1 (CB1) receptor. It is specifically indicated as an adjunct to diet and exercise for the treatment of obese patients (body mass index [BMI]≥30 kg/m2), or overweight patients (BMI>27 kg/m2) with associated risk factors such as type 2 diabetes or dyslipidemia. Additionally, rimonabant is currently under development as a treatment for nicotine dependence. The CB1 and CB2 receptors, along with their endogenous ligands, constitute the endocannabinoid system. The CB1 receptor is expressed in the brain, adipose tissue, and several peripheral organs; the CB2 receptor is predominantly expressed in immune cells. Activation of the CB1 receptor in the CNS is associated with appetite stimulation and the modulation of brain reward mechanism, whereas activation in the periphery favors metabolic processes that lead to hepatic lipogenesis and impaired glucose homeostasis. Rimonabant acts by selectively blocking the action of central and peripheral CB1 receptors, thereby reducing food intake and improving lipid and glucose metabolism.
InChI:InChI=1/C22H21Cl3N4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-9-17(24)13-18(19)25)21(14)15-5-7-16(23)8-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30)
Articles related to Rimonabant:
|
Article |
Source |
|
Process for Making Biologically Active Compounds and Intermediates Thereof |
- , (2022/02/05) |
|
PYRAZOLE CARBOXYLIC ACID ANALOGUES AS ANTI-MYCOBACTERIAL DRUG CANDIDATES |
- Page/Page column 14; 15, (2014/11/13) |
How to get the best price on Rimonabant?
Ningbo EST Chemical Co., Ltd is a quality supplier and manufacturer of Rimonabant . You can buy high quality, low price Rimonabant 168273-06-1 here. Contact us.